Gene correction for SCID-X1 in long-term hematopoietic stem cells
Gene correction in hematopoietic stem cells could be a powerful way to treat monogenic diseases of the blood and immune system. Here the authors develop a strategy using CRISPR-Cas9 and an aAdeno-Associated vVirus(AAV)-delivered IL2RG cDNA to correct X-linked sSevere Ccombined iImmunodeficiency (SCI...
Saved in:
Main Authors: | Mara Pavel-Dinu, Volker Wiebking, Beruh T. Dejene, Waracharee Srifa, Sruthi Mantri, Carmencita E. Nicolas, Ciaran Lee, Gang Bao, Eric J. Kildebeck, Niraj Punjya, Camille Sindhu, Matthew A. Inlay, Nivedita Saxena, Suk See DeRavin, Harry Malech, Maria Grazia Roncarolo, Kenneth I. Weinberg, Matthew H. Porteus |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/66cf921ac2ec4178bebe47ca77ff7c87 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells
by: Mara Pavel-Dinu, et al.
Published: (2019) -
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells
by: Mara Pavel-Dinu, et al.
Published: (2019) -
Cas9-AAV6-engineered human mesenchymal stromal cells improved cutaneous wound healing in diabetic mice
by: Waracharee Srifa, et al.
Published: (2020) -
Reevaluation of NOD/SCID Mice as NK Cell-Deficient Models
by: Miao Miao, et al.
Published: (2021) -
Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy
by: Federico A. Moretti, et al.
Published: (2021)